DiaMedica Therapeutics Inc
DiaMedica Therapeutics Inc (DMAC) Option Chain
As of September 17, 2026, DiaMedica Therapeutics Inc is trading at $6.85, a +3.32% change from the previous close. The nearest expiration is Sep 18, 2026. Implied volatility is 182.2%. IV Rank is 75%.
Read more
Tracking the DMAC option chain helps you see every strike and expiry on DiaMedica Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. DiaMedica Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of DMAC options activity at a glance. Use our scanner to monitor the DMAC option chain in real time and filter for the DMAC options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For DMAC stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the DMAC option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where DMAC stock options are being actively traded and where they are not.
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type I or Type II diabetes; and Phase 2/3 REMEDY2 trials for the treatment of patients with acute ischemic stroke. It is also developing DM300 that is in pre-clinical stage for the treatment of inflammatory diseases. The company was formerly known as DiaMedica Inc.
and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls DiaMedica Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen DMAC options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of DMAC stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile79.76% Elevated
- Market cap (M$)369
- 52 weeks high-34.26%
- 52 weeks low30.73%
- Analyst recommendationStrong Buy
1.00 - Target price$15.50
126.28% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-11
- P/E—
- Future P/E—
- EPS (ttm)-0.71
- EPS growth next 5 years-9.82%
As of September 17, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 0.00 | 0 | 0 | 0.65 | 4.35 | 3.50 | 6.50 | 2.50 | -62.29 | — | 2.95 | 0.00 | 2.95 | 0 | 0 | 100.00 |
| 0.03 | 6 | 0 | 0.65 | 1.85 | 0.30 | 4.70 | 5.00 | -24.59 | — | 0.25 | 0.00 | 0.25 | 0 | 0 | 99.97 |
| 94.04 | 37 | 0 | 0.40 | 0.00 | — | 0.40 | 7.50 | +13.12 | 0.40 | 1.55 | 0.65 | 0.32 | 0 | 0 | 5.96 |
| 100.00 | 0 | 0 | 1.75 | 0.00 | — | 1.75 | 10.00 | +50.83 | 2.80 | 6.00 | 3.15 | 1.25 | 0 | 0 | 0.00 |
| 100.00 | 2 | 0 | 1.50 | 0.00 | — | 1.50 | 12.50 | +88.54 | 4.00 | 8.50 | 5.65 | 0.60 | 0 | 0 | 0.00 |
As of September 17, 2026
Scan the full option chain in one place
Browse the full DMAC option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→